Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Molecular alterations of the blood-brain barrier under inflammatory conditions: The role of endothelial to mesenchymal transition.
Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.
Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive function.
Carbon Monoxide and Central Nervous System: Challenges and Achievements.
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature.
Poor responses to interferon-Beta treatment in patients with neuromyelitis optica and multiple sclerosis with long spinal cord lesions.
Specialty drug spending trends among medicare and medicare advantage enrollees, 2007-11.
Genome-wide association studies in neurology.
Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
Respiratory dysfunction in multiple sclerosis.
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.
The HV3 Score: A New Simple Tool to Suspect Cognitive Impairment in Multiple Sclerosis in Clinical Practice.
Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.
The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
[Demyelinating process in systematic rheumatoid diseases (review)].
Plasma Exchange for Steroid-Refractory Relapses in Multiple Sclerosis: An Observational, MRI Pilot Study.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.

Pages